Literature DB >> 8298810

Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit.

A Sala1, G Rossoni, C Buccellati, F Berti, G Folco, J Maclouf.   

Abstract

1. We have studied the transcellular biosynthesis of bioactive leukotrienes (LTs), generated upon blood cell-vascular wall interactions and their functional consequences, in the spontaneously beating, cell-perfused, heart of the rabbit. Rabbit isolated hearts were perfused under recirculating conditions (50 ml) with 5 x 10(6) cells of unpurified (buffy coat) or purified human neutrophils (PMNL), and challenged with 0.5 microM A23187 for 30 min. Coronary perfusion pressure (CPP), heart rate (HR), left ventricular end-diastolic pressure (LVEDP) and left ventricular pressure (LVP) were monitored continuously. Leukotriene formation was measured by specific enzyme-immunoassay and confirmed by reversed phase h.p.l.c. and u.v. spectral analysis. 2. Basal CPP values averaged 44 +/- 1.4 mmHg; A23187 triggered a marked increase in CPP both in the presence of buffy coat cells (+100% above basal) and PMNL (+270% above basal); the latter change in CPP was accompanied by a rise in LVEDP (+138% above basal). 3. The increase in CPP was preceded by a statistically significant rise in iLTC4-D4 concentration in the circulating buffer. Pretreatment with two structurally unrelated LTD4 receptor antagonists, LY171883 and SKF104353 (10 microM), fully prevented the increase in CPP and LVEDP. A similar protection was also observed when the rabbit heart was perfused with PMNL that had been pretreated with MK886 (1 microM), a potent inhibitor of leukotriene biosynthesis. 4. The increased coronary tone was accompanied by a marked release of lactate dehydrogenase (LDH), a marker of ischaemic damage; pretreatment of the heart with the LTD4 receptor antagonists as well as of the PMNL with MK886 resulted in a complete suppression of LDH activity release. 5. Positive identification of LTC4-D4 in the perfusates was obtained and a significant correlation observed between the CPP values and iLTC4-D4 concentrations.6. This study suggests that challenge of PMNL present within the coronary vasculature, causes a LTD4-dependent coronary vasoconstriction, favoured by an efficient uptake of PMNL-derived LTA4 by endothelial cells. The activation of the 5-lipoxygenase pathway in the context of tight interactions between blood cells and coronary vasculature, is suggested to have an important outcome in the alterations of coronary flow and cardiac contractility.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298810      PMCID: PMC2175811          DOI: 10.1111/j.1476-5381.1993.tb13943.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Vascular smooth muscle cell leukotriene C4 synthesis: requirement for transcellular leukotriene A4 metabolism.

Authors:  S J Feinmark; P J Cannon
Journal:  Biochim Biophys Acta       Date:  1987-11-21

Review 2.  Leukotrienes.

Authors:  P J Piper; M N Samhoun
Journal:  Br Med Bull       Date:  1987-04       Impact factor: 4.291

3.  Nonsteroidal antiinflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart: a role for prostacyclin.

Authors:  F Berti; G Rossoni; F Magni; D Caruso; C Omini; L Puglisi; G Galli
Journal:  J Cardiovasc Pharmacol       Date:  1988-10       Impact factor: 3.105

4.  Influence of microvascular adherence on neutrophil leukotriene generation. Evidence for cooperative eicosanoid synthesis.

Authors:  F Grimminger; B Kreusler; U Schneider; G Becker; W Seeger
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

5.  Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes.

Authors:  G I Johnston; G A Bliss; P J Newman; R P McEver
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

6.  L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor.

Authors:  J Gillard; A W Ford-Hutchinson; C Chan; S Charleson; D Denis; A Foster; R Fortin; S Leger; C S McFarlane; H Morton
Journal:  Can J Physiol Pharmacol       Date:  1989-05       Impact factor: 2.273

7.  Transcellular sulfidopeptide leukotriene biosynthetic capacity of vascular cells.

Authors:  J Maclouf; R C Murphy; P M Henson
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

8.  FMLP causes eicosanoid-dependent vasoconstriction and edema in lungs from endotoxin-primed rats.

Authors:  N F Voelkel; J Czartolomna; J Simpson; R C Murphy
Journal:  Am Rev Respir Dis       Date:  1992-03

9.  Development of enzyme immunoassays for leukotrienes using acetylcholinesterase.

Authors:  C Antoine; J P Lellouche; J Maclouf; P Pradelles
Journal:  Biochim Biophys Acta       Date:  1991-10-10

10.  Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation.

Authors:  M Carry; V Korley; J T Willerson; L Weigelt; A W Ford-Hutchinson; P Tagari
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

View more
  7 in total

1.  Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention.

Authors:  Chinthalapally V Rao; Naveena B Janakiram; Altaf Mohammed
Journal:  Curr Colorectal Cancer Rep       Date:  2012-12

Review 2.  Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma.

Authors:  Erwin W Gelfand
Journal:  Semin Immunol       Date:  2017-10       Impact factor: 11.130

Review 3.  The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.

Authors:  Malvina Hoxha; G Enrico Rovati; Aurora Bueno Cavanillas
Journal:  Eur J Clin Pharmacol       Date:  2017-04-04       Impact factor: 2.953

4.  14,15-Dehydroleukotriene A4: a specific substrate for leukotriene C4 synthase.

Authors:  A Sala; M Garcia; S Zarini; J C Rossi; G Folco; T Durand
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

Review 5.  Transcellular biosynthesis of eicosanoids.

Authors:  Angelo Sala; Giancarlo Folco; Robert C Murphy
Journal:  Pharmacol Rep       Date:  2010 May-Jun       Impact factor: 3.024

6.  Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.

Authors:  N F Voelkel; R M Tuder; K Wade; M Höper; R A Lepley; J L Goulet; B H Koller; F Fitzpatrick
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

Review 7.  Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs.

Authors:  J Martel-Pelletier; D Lajeunesse; P Reboul; J-P Pelletier
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.